An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression

Oren M. Becker*, Dale S. Dhanoa, Yael Marantz, Dongli Chen, Sharon Shacham, Srinivasa Cheruku, Alexander Heifetz, Pradyumna Mohanty, Merav Fichman, Anurag Sharadendu, Raphael Nudelman, Michael Kauffman, Silvia Noiman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

138 Scopus citations

Fingerprint

Dive into the research topics of 'An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds